Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycatsnews2025-04-16T14:43:02+00:00April 16th, 2025|The New York Times|
Trump’s Tariff Threat for Drug imports Poses Big Political Risksnews2025-04-15T14:33:12+00:00April 15th, 2025|The New York Times|
Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugsnews2025-04-04T23:42:16+00:00April 4th, 2025|The New York Times|
Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticalsnews2025-04-04T09:00:28+00:00April 4th, 2025|The New York Times|
FDA Layoffs Could Raise Drug Costs and Erode Food Safetynews2025-04-04T01:59:02+00:00April 4th, 2025|The New York Times|
How Much Should Weight Loss Drugs Like Wegovy and Zepbound Cost?news2025-03-14T15:00:05+00:00March 14th, 2025|The New York Times|
Weight Loss Drug Will Be Offered for $499 a Month for Some Patientsnews2025-03-05T19:09:26+00:00March 5th, 2025|The New York Times|
Medicare Doesn’t Pay for Everything: How to Bridge the Cost Gapnews2025-02-15T10:00:50+00:00February 15th, 2025|The New York Times|
In China, Government Data on Drugs Blocked From Public After Backlashnews2025-01-27T10:51:18+00:00January 27th, 2025|The New York Times|
In China, Rare Dissent Over a Program to Save on Drug Costsnews2025-01-25T05:00:05+00:00January 25th, 2025|The New York Times|
